These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 24819859)

  • 1. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
    Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
    Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
    Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
    Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
    Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
    Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
    Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
    Bogan CM; Kaczmarek JV; Pierce JM; Chen SC; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Nadelmann JB; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
    Br J Ophthalmol; 2022 Feb; 106(2):288-296. PubMed ID: 33972235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
    Francis JH; Abramson DH; Gaillard MC; Marr BP; Beck-Popovic M; Munier FL
    Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL
    Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
    Chao A; Kao LY; Liu L; Wang NK
    BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL; Gaillard MC; Balmer A; Soliman S; Podilsky G; Moulin AP; Beck-Popovic M
    Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model.
    Kaczmarek JV; Bogan CM; Pierce JM; Tao YK; Chen SC; Liu Q; Liu X; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Friedman DL; Richmond A; Daniels AB
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):8. PubMed ID: 34757417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intravitreal topotecan toxic to retinal function?
    Nadelmann J; Francis JH; Brodie SE; Muca E; Abramson DH
    Br J Ophthalmol; 2021 Jul; 105(7):1016-1018. PubMed ID: 32665221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOXICITY AND EFFICACY OF INTRAVITREAL MELPHALAN FOR RETINOBLASTOMA: 25 µg Versus 30 µg.
    Liao A; Hsieh T; Francis JH; Lavery JA; Mauguen A; Brodie SE; Abramson DH
    Retina; 2021 Jan; 41(1):208-212. PubMed ID: 32106160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
    Xue K; Ren H; Meng F; Zhang R; Qian J
    BMC Ophthalmol; 2019 Feb; 19(1):61. PubMed ID: 30808420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INTRAVITREAL MELPHALAN AS SALVAGE THERAPY FOR REFRACTORY RETINAL AND SUBRETINAL RETINOBLASTOMA.
    Francis JH; Marr BP; Brodie SE; Gobin P; Dunkel IJ; Abramson DH
    Retin Cases Brief Rep; 2016; 10(4):357-60. PubMed ID: 26630243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.